They appear to be hitting some milestones. The Sydney plant has TGA approval, a deal has been done with the QLD Gov for a new 1m Ltr facility and their Covid Hyperimmune is nearing completion of final trials (for the technically minded there is a report coauthored with Kirby Institute explaining impressive outcomes). If their (Aegros) latest YouTube video is taken at face value, Macquarie are casting around for a cornerstone investor at a $1b valuation.
if things are as good as they look it makes me wonder why CSL haven’t bought them out? Why allow a competitor with superior technology (in theory) to get established?
They appear to be hitting some milestones. The Sydney plant has...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$275.00 |
Change
1.700(0.62%) |
Mkt cap ! $132.8B | |||
| Open | High | Low | Value | Volume |
| $274.75 | $275.49 | $272.56 | $122.9M | 448.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40 | $274.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $275.01 | 685 | 1 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$275.00 |
Change
1.700 ( 0.60 %) |
||||
| Open | High | Low | Volume | ||
| $274.80 | $275.48 | $272.60 | 29224 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| CSL (ASX) Chart |